Skip to main content
TipRanks
Go Ultimate75% OFF

TOT BIOPHARM International Co. Ltd. (1875) Income Statement

0 Followers

TOT BIOPHARM International Co. Ltd. Income Statement

Last quarter (Q2 2026), TOT BIOPHARM International Co. Ltd.'s total revenue was ¥242.62M, a decrease of 53.40% from the same quarter last year. In Q2, TOT BIOPHARM International Co. Ltd.'s net income was ¥-57.71M. See TOT BIOPHARM International Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 747.64M¥ 1.10B¥ 780.63M¥ 442.18M¥ 76.33M
¥ 388.98M¥ 782.43M¥ 573.99M¥ 370.62M¥ 27.47M
¥ 479.67M¥ 741.18M¥ 607.05M¥ 409.45M¥ 287.17M
Depreciation and Amortization¥ 79.20M¥ 65.42M¥ 43.03M¥ 38.04M¥ 34.24M
¥ -1.29M¥ 111.58M¥ 10.45M¥ -5.41M¥ -224.51M
¥ -90.69M¥ 41.25M¥ -33.06M¥ -39.08M¥ -259.70M
¥ -9.68M¥ -6.50M¥ -4.70M¥ -10.97M¥ -1.52M
¥ -100.37M¥ 34.76M¥ -37.76M¥ -50.05M¥ -261.22M
¥ -100.37M¥ 34.76M¥ -37.76M¥ -49.92M¥ -261.22M
Per Share Metrics
Basic EPS¥ -0.14¥ 0.05¥ -0.05¥ -0.08¥ -0.46
Diluted EPS¥ -0.14¥ 0.05¥ -0.05¥ -0.08¥ -0.46
Weighted Average Shares Outstanding725.20M725.20M725.20M639.31M573.36M
Weighted Average Shares Outstanding (Diluted)725.20M725.20M725.20M639.31M573.36M

Currency in CNY

TOT BIOPHARM International Co. Ltd. Earnings and Revenue History

-600M0600M1.2B-1600 %-800 %0 %800 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin